Veravas, Inc. news
On June 27, Alex Wittenberg at the Minneapolis/St. Paul Business Journal published a profile of Veravas, highlighting both its long-term potential in the billion-dollar IVD market and the upcoming launch of its first suite of products.
“Veravas Inc., founded last year, says it`s developed a novel technology with the potential to change the way conditions such as Alzheimer`s and sleep apnea are diagnosed. If successful, the company, whose chief lab is in Oakdale, could make a spl
VeraPrep Antibody Detection kit, to be introduced at AACC, allows researchers to measure antibodies against any antigen of interest in serum, plasma or saliva.
Austin, TX, September 27, 2021 -- Veravas, Inc., an early-stage diagnostics company, has announced the development of its VeraPrep™ Antibody Detection Kit, a new development platform that provides scientists with a state-of-the-art research tool to easily and quickly develop
CHARLESTON, S.C. and OAKDALE, Minn., March, 13 2020, - Veravas, Inc., an emerging diagnostic company focusing on sample preparation products and new diagnostic tests and MIP Diagnostics Ltd.,the Molecularly Imprinted Polymers (MIPs) specialist based in Sharnbrook, United Kingdom,announced today that they have entered into a mutually beneficial agreement for the development, license, and supply of a novel MIP specific for Veravas’ proprietary sample preparation tech
CHARLESTON,S.C. and OAKDALE, Minn., January, 13 2020, - Veravas, Inc. and Tymora Analytical Operations, LLC announced today that they have entered into a strategic alliance to explore the integration of their respective technologies. Veravas is an emerging diagnostic company focused on proprietary sample preparation products and new diagnostic tests. Tymora’s focus is on providing diagnostic and therapeutic biomarker discovery contract services and products. Togeth
Veravas enjoyed meeting all of you and exhibiting at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, August 4th-8th at Booth #1469.